Inflammatory markers and delirium in the intensive care unit

Basit Öğe Kaydı
dc.contributor.authorYildiz, Sevler
dc.contributor.authorUslu, Muhammed Fuad
dc.contributor.authorEmir, Burcu Sirlier
dc.contributor.authorKurt, Osman
dc.date.accessioned2026-04-04T13:32:56Z
dc.date.available2026-04-04T13:32:56Z
dc.date.issued2025
dc.departmentİnönü Üniversitesi
dc.description.abstractBackground: Delirium is an important complication in patients admitted to intensive care unit (ICU). However, delirium prediction in patients admitted to the ICU is difficult. Considering the role of neuroinflammation in delirium, peripheral blood-based biomarkers of inflammation pressure could predict delirium. The aim of study was to retrospectively analyze ratios of neutrophil/high density lipoprotein (HDL) (NHR), lymphocyte/HDL (LHR), platelet/HDL (PHR), monocyte/HDL (MHR), as well as systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) in ICU patients diagnosed with delirium. Methods: The study included a total of 2141 patients with or without delirium. The risk factors for delirium development and the predictive power of individual laboratory parameters were evaluated with the Pearson chi-square test, Mann-Whitney U test, Spearman correlation test, logistic regression, and receiver operating characteristic analyses. Results: Length of ICU stay (p < 0.001), NHR (p = 0.035), LHR (p < 0.001), PHR (p = 0.047), MHR (p < 0.001), SIRI (p < 0.001), and SII (p < 0.001) were significantly higher in patients who developed delirium compared to those who did not. A significant negative correlation was found between the duration of delirium and SII (r = -0.260; p = 0.004). Older age, a history of psychiatric treatment, prolonged hospitalization, and high LHR, SIRI, and SII values were determined as risk factors for delirium (p < 0.05 for all). Conclusions: Elevated LHR, SIRI, and SII levels before ICU admission are associated with an increased risk of hyperactive delirium. If confirmed by prospective evidence, readily available biomarkers for inflammation could be used to evaluate the hyperactive delirium risk in ICUs.
dc.identifier.doi10.22514/sv.2025.133
dc.identifier.endpage98
dc.identifier.issn1334-5605
dc.identifier.issn1845-206X
dc.identifier.issue9
dc.identifier.orcid0000-0003-4164-3611
dc.identifier.scopus2-s2.0-105016360612
dc.identifier.scopusqualityQ3
dc.identifier.startpage91
dc.identifier.urihttps://doi.org/10.22514/sv.2025.133
dc.identifier.urihttps://hdl.handle.net/11616/108789
dc.identifier.volume21
dc.identifier.wosWOS:001568281900012
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMre Press
dc.relation.ispartofSigna Vitae
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250329
dc.subjectIntensive care
dc.subjectDelirium
dc.subjectNeutrophil/high-density lipoprotein
dc.subjectLymphocyte/high-density lipoprotein
dc.subjectPlatelet/high-density lipoprotein
dc.subjectMonocyte/high-density lipoprotein
dc.subjectSys-temic immune-inflammation index
dc.subjectSystemic inflammatory response index
dc.titleInflammatory markers and delirium in the intensive care unit
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu